Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
CANO.WS was delisted on the 9th of November, 2023.
19 hedge funds and large institutions have $3M invested in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
38% more capital invested
Capital invested by funds: $2.18M → $3M (+$824K)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
5% less funds holding
Funds holding: 20 → 19 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
+$142K |
| 2 |
CAC
Cowen and Company
New York
|
+$112K |
| 3 |
JAIC
Josh Arnold Investment Consultant
Edina,
Minnesota
|
+$91K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
-$190K |
| 2 |
FTUS
Flow Traders U.S.
New York
|
-$2K |
| 3 |
BlackRock
New York
|
-$128 |
CANO.WS Hedge Fund Activity: Q2 2023 in Review
19 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) for Q2 2023, worth a combined $3M — up 38% from $2.18M a quarter earlier.
Fund positioning in CANO.WS was balanced in Q2 2023: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 2 trimmed.
The largest buyer was Barclays, adding an estimated $142K. The largest seller was Ionic Capital Management, cutting an estimated $190K.
- 19 institutional investors held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) as of Q2 2023, down from 20 in Q1 2023.
- Funds reported $3M of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 stock for Q2 2023, up 38% quarter-over-quarter.
- 1 fund opened new Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 positions in Q2 2023 and 1 closed out, a net change of 0 holders.
- The largest Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 buyer in Q2 2023 was Barclays, an estimated $142K added.
- The largest Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 seller in Q2 2023 was Ionic Capital Management, an estimated $190K sold.
Based on aggregated 13F filings for Q2 2023.